HaystackAnalytics is a precision diagnostics and clinical genomics company that leverages Next-Generation Sequencing (NGS), bioinformatics, and artificial intelligence to transform disease diagnosis and personalized healthcare. The company's portfolio includes genomic solutions for infectious disease detection, antimicrobial resistance profiling, inherited disease testing, and pharmacogenomics. Through its healthcare platforms—including identifi, its consumer genomics offering— HaystackAnalytics aims to make advanced genomic testing more accessible, enabling clinicians and patients to make informed, data-driven healthcare decisions.